123 related articles for article (PubMed ID: 7148465)
1. [Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant].
Chen ZY; Chen LF; Gong XQ
Yao Xue Xue Bao; 1982 Jun; 17(6):425-30. PubMed ID: 7148465
[No Abstract] [Full Text] [Related]
2. Synthesis of immunologically active muramyl dipeptide derivatives containing a quinonyl moiety via aminoacyl intermediates.
Fukuda T; Kobayashi S; Yukimasa H; Imada I; Fujino M; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2215-21. PubMed ID: 7318034
[No Abstract] [Full Text] [Related]
3. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities.
Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I
Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine.
Ishida H; Kitagawa M; Kiso M; Hasegawa A; Azuma I
Carbohydr Res; 1990 Dec; 208():267-72. PubMed ID: 2085813
[No Abstract] [Full Text] [Related]
5. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].
Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV
Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137
[TBL] [Abstract][Full Text] [Related]
6. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunoadjuvant activity of 2,2'-O-[2,2'-diacetamido-2,3,2',3'-tetradeoxy-6,6'-di-O-(2-tetradecyl- hexadecanoyl)-alpha,alpha'-trehalose-3,3'-diyl]bis(N-D-lactoyl-L-alanyl -D-isoglutamine).
Ishida H; Imai Y; Kiso M; Hasegawa A; Sakurai T; Azuma I
Carbohydr Res; 1989 Dec; 195(1):59-66. PubMed ID: 2636046
[TBL] [Abstract][Full Text] [Related]
8. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
[TBL] [Abstract][Full Text] [Related]
9. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
[No Abstract] [Full Text] [Related]
10. Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccines.
Lidgate DM; Byars NE
Pharm Biotechnol; 1995; 6():313-24. PubMed ID: 7551223
[No Abstract] [Full Text] [Related]
11. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation.
Solange A
Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of biologically active biotinylated muramyl dipeptides.
Grimes CL; Podolsky DK; O'Shea EK
Bioorg Med Chem Lett; 2010 Oct; 20(20):6061-3. PubMed ID: 20822907
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
Durette PL; Dorn CP; Friedman A; Schlabach A
J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido-2,3,di-deoxy-6-thio-D-glucopyranose-3-yl)-D-lac toy l]-L- alanyl-D-isoglutamine derivatives.
Hasegawa A; Seki E; Hioki Y; Kiso M; Azuma I
Carbohydr Res; 1984 Jul; 129():271-7. PubMed ID: 6467247
[No Abstract] [Full Text] [Related]
15. Synthesis and biological activity of some lipophilic derivatives of 1-thio-muramoyl-L-alanyl-D-isoglutamine.
Hasegawa A; Seki E; Hioki Y; Kiso M; Azuma I
Carbohydr Res; 1984 Aug; 131(1):61-9. PubMed ID: 6488202
[TBL] [Abstract][Full Text] [Related]
16. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
[No Abstract] [Full Text] [Related]
17. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
Adam A; Souvannavong V; Lederer E
Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
[No Abstract] [Full Text] [Related]
18. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
[TBL] [Abstract][Full Text] [Related]
19. Behavioural effects of muramyl dipeptide and adamantylamide dipeptide in mice.
Sulcová A; Krsiak M; Masek K; Gulda O
Act Nerv Super (Praha); 1989 Jun; 31(2):127-9. PubMed ID: 2800947
[No Abstract] [Full Text] [Related]
20. Synthesis of (N-acetyl-1-O-acylmuramoyl)-L-alanyl-D-isoglutamines, and their immunoadjuvant activities.
Hasegawa A; Hioki Y; Kiso M; Azuma I
Carbohydr Res; 1983 Nov; 123(1):63-71. PubMed ID: 6667479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
